Why Ketamine Works Differently Than Standard Anxiety Medications
Most anxiety medications — SSRIs, SNRIs (serotonin-norepinephrine reuptake inhibitors), and benzodiazepines — work by modulating serotonin, norepinephrine, or GABA (gamma-aminobutyric acid, the brain’s primary inhibitory neurotransmitter). These are established pathways, and these medications help many people. But they don’t help everyone, and even when they do help, the lag time before relief begins can be substantial.
Ketamine is an NMDA (N-methyl-D-aspartate) receptor antagonist. NMDA receptors are a type of glutamate receptor — glutamate being the brain’s primary excitatory neurotransmitter. By blocking these receptors, ketamine triggers a downstream release of neurotransmitters and promotes synaptogenesis (the formation of new connections between neurons) and neuroplasticity (the brain’s capacity to reorganize and form new neural pathways). This cascade happens rapidly — which is why ketamine’s effects on mood and anxiety can emerge in a timeframe measured in hours rather than weeks. For a deeper dive into how ketamine works for anxiety and depression, our dedicated post covers the underlying science in detail.
This speed is not incidental. For patients in acute distress, or those who have spent months or years without adequate relief from conventional treatments, the rapidity of response is clinically meaningful. Results vary by individual, and ketamine is not appropriate for everyone — a thorough evaluation is part of any responsible treatment process. But for patients who qualify, the timeline is often dramatically different from what they’ve experienced before.
The Clinical Timeline: What Research Shows
A 2022 systematic review published in the British Journal of Clinical Pharmacology synthesized the available evidence on ketamine for refractory anxiety — anxiety that has not responded adequately to conventional treatment. The review found that treatment responses were evident as early as 3 hours post-infusion and persisted up to 14 days in some cases. In open-label studies with patients diagnosed with generalized anxiety disorder (GAD, a condition characterized by persistent, excessive worry) and social anxiety disorder (SAD, marked by intense fear of social situations), rapid onset effects were visible within 1 hour post-infusion and lasted up to a week (Tully et al., 2022).
A randomized, placebo-controlled crossover trial published in Neuropsychopharmacology examined ketamine specifically for social anxiety disorder in 18 adults. A single IV infusion of ketamine at 0.5 mg/kg produced significant reductions in anxiety scores at 3 hours post-infusion, with benefits sustained at days 2, 5, and 10 compared to placebo. Notably, 88.89% of ketamine recipients showed a greater than 50% reduction on a self-reported anxiety visual analog scale, compared to 52.94% of placebo recipients (Glue et al., 2017).
These findings point to a consistent pattern: ketamine produces anxiolytic effects — anxiety reduction — relatively quickly after infusion, and those effects persist for days to over a week following a single treatment in some patients. A series of infusions, rather than a single treatment, is typically what produces more durable benefit. The optimal protocol varies by individual and is something we assess and discuss during the consultation process.
What a Ketamine Infusion Experience Looks Like at Our Clinic
Before any infusion begins, patients meet with Dr. Brandon Grinage, MD, or Wesley Karcher, MSN, CRNA, for a thorough consultation that includes a review of medical and psychiatric history, current medications, and treatment goals. This isn’t a formality — it’s the foundation of safe, appropriate care. Our providers are both anesthesia specialists, which means the precision of dosing and the management of any physiological responses during infusion are areas of deep expertise, not approximation. You can learn more about our providers and their backgrounds before scheduling.
Mental health infusions at our Marietta clinic typically run 40 to 60 minutes, conducted in a private, comfortable treatment room. Patients remain clothed and may have one family member or support person present during the infusion. Vital signs are monitored continuously throughout. After the infusion, there is approximately 30 minutes of relaxation time before discharge. Patients should not drive themselves home, so arranging transportation in advance is part of our pre-treatment guidance.
During the infusion, patients commonly experience some degree of dissociation — a temporary, dose-related shift in perception that resolves as the medication clears. This is an expected pharmacological effect, not a side effect in the concerning sense, and it passes well within the treatment window. Our team prepares patients for what to expect before the infusion begins so there are no surprises.
Realistic Expectations: Duration and Maintenance
The acute anxiolytic effect from a single ketamine infusion — the window of symptom reduction that follows immediately — typically lasts from several days to two weeks. For most patients seeking treatment for anxiety, a series of infusions spaced over two to three weeks is the standard starting point, with the full protocol tailored to individual response. Some patients maintain benefit for extended periods following an initial series; others find that periodic maintenance infusions help sustain the improvement.
We are direct with patients that ketamine is a treatment, not a cure, and individual response varies. Some patients experience substantial, sustained improvement; others find it helpful as one component of a broader treatment approach. What we can offer with confidence is a clinical environment where the treatment is administered by experienced anesthesia providers, where monitoring is thorough, and where expectations are set honestly before any commitment is made.
SPRAVATO® (esketamine nasal spray), FDA-approved for treatment-resistant depression, works through a similar glutamatergic mechanism and is another option we discuss with qualifying patients. For those whose primary presentation includes treatment-resistant depression alongside anxiety, SPRAVATO® may be relevant to explore. We accept Anthem BCBS, Aetna, and Medicare, and SPRAVATO® carries broader insurance coverage for qualifying patients than IV ketamine.
Addressing Common Barriers to Getting Started
One concern we hear frequently is fear of what ketamine “does to you” — rooted partly in its cultural reputation as a recreational substance. Ketamine has been used continuously in medical settings since FDA approval as an anesthetic in 1970. At the doses and in the controlled clinical environment we provide, it is a well-understood pharmacological agent, not an experimental unknown. Patients who have reservations are encouraged to bring those questions directly to their consultation with our providers — we would rather spend extra time on that conversation than have a patient proceed with unresolved uncertainty.
The other practical barrier is cost. IV ketamine infusions at our clinic range from $400 to $1,000 per treatment. We offer a 15% discount for patients who pay upfront for an initial series, and a 25% discount for active military, veterans, and first responders. CareCredit financing is accepted for patients managing out-of-pocket expenses. Our front desk team is prepared to walk through costs transparently before any treatment decisions are finalized, because we believe financial clarity is part of informed consent.
Frequently Asked Questions
How quickly can I expect to feel relief from ketamine for anxiety?
Research shows anxiolytic effects can emerge as early as 1 to 3 hours post-infusion, with some patients noticing changes the same day. The duration varies — effects from a single infusion typically last several days to two weeks. Results vary by individual, and a series of infusions is usually needed to assess full response and build more durable benefit.
Is ketamine FDA-approved for anxiety?
Ketamine is FDA-approved as an anesthetic, and SPRAVATO® is FDA-approved specifically for treatment-resistant depression. The use of IV ketamine for anxiety disorders is off-label, meaning it is prescribed by providers for a use outside its FDA approval based on clinical evidence. Many psychiatric treatments are used off-label; your provider can discuss this distinction in the context of your specific situation.
How many infusions does it typically take before anxiety improves?
Many patients notice some reduction in anxiety within the first one to three infusions, though the degree of response and how long it lasts varies. A standard initial series usually involves multiple infusions over two to three weeks, after which response is evaluated. Discuss your expectations and history with your provider before beginning so you have a clear picture of what to watch for.
Can ketamine be used alongside my current anxiety medication?
In many cases, yes — though this depends on which medications you’re taking and your full medical history. This is assessed during your consultation. We do not make blanket recommendations; your current medication regimen will be reviewed before any treatment begins, and adjustments are made collaboratively based on what’s safest and most effective for you.
What happens if ketamine doesn’t work for my anxiety?
Ketamine is not effective for everyone, and we communicate that clearly. If you do not respond adequately to an initial series, your provider will discuss what that means for next steps — whether that’s a protocol adjustment, a different treatment modality, or referral for additional support. Our goal is honest, individualized care rather than continued treatment in the absence of meaningful response.
Key Takeaways
- Ketamine works through the glutamatergic system rather than serotonin or norepinephrine pathways, producing anxiolytic effects that can emerge within 1 to 3 hours of infusion — far faster than standard anxiety medications.
- A 2022 systematic review found treatment responses evident 3 hours post-infusion, persisting up to 14 days in some cases (Tully et al., 2022).
- A randomized, placebo-controlled trial found that 88.89% of patients with social anxiety disorder showed a greater than 50% anxiety reduction on a self-reported scale following a single ketamine infusion (Glue et al., 2017).
- A standard treatment course involves multiple infusions rather than a single session; individual response and protocol are assessed and tailored during the consultation process.
- Results vary by individual, and ketamine is best approached as a treatment for people who haven’t achieved adequate relief through conventional options — not a first-line intervention.
Speed of response matters when you’ve been waiting a long time for relief. If conventional anxiety treatments haven’t given you adequate improvement, ketamine’s distinct biological mechanism may offer a different outcome — and the research supports that possibility. Call us at 770-580-1042 or request a free consultation at theinvictusclinic.com to discuss your history with our team and explore whether IV ketamine infusion therapy is right for you.
References
Glue, P., Medlicott, N. J., Harland, S., Neehoff, S., Anderson-Fahey, B., Le Nedelec, M., Gray, A., & McNaughton, N. (2017). Ketamine for social anxiety disorder: A randomized, placebo-controlled crossover trial. Neuropsychopharmacology, 42(6). https://pmc.ncbi.nlm.nih.gov/articles/PMC5729569/
Tully, J. L., Dahlén, A. D., Haggarty, C. J., Schiöth, H. B., & Brooks, S. (2022). Ketamine treatment for refractory anxiety: A systematic review. British Journal of Clinical Pharmacology, 88(10). https://pmc.ncbi.nlm.nih.gov/articles/PMC9540337/
Medical Disclaimer: The information in this blog is for educational purposes only and does not constitute medical advice. Treatment for anxiety, depression, and related conditions — including IV ketamine infusion therapy and SPRAVATO® — should only be pursued under the supervision of a licensed provider familiar with your full medical and psychiatric history. Individual results vary. IV ketamine for anxiety disorders is used off-label; SPRAVATO® is FDA-approved for specific indications. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.
